Biofrontera
BFRIW
5 hedge funds and large institutions have $1.11M invested in Biofrontera in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
+$453K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$39.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.93K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$2.7K |
Top Sellers
BFRIW Hedge Fund Activity: Q4 2021 in Review
5 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q4 2021, worth a combined $1.11M.
Buyers outnumbered sellers: 5 funds opened new BFRIW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bard Associates, opening a new position worth an estimated $453K.
- 5 institutional investors held Biofrontera (BFRIW) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $1.11M of Biofrontera stock for Q4 2021.
- 5 funds opened new Biofrontera positions in Q4 2021 and 0 closed out, a net change of +5 holders.
- The largest Biofrontera buyer in Q4 2021 was Bard Associates, an estimated $453K added.
Based on aggregated 13F filings for Q4 2021.